More than 150 countries engaged in COVID-19 vaccine global access facility
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
-
-
HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmission
On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…
-
BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
-
BD announced purchase agreement with U.S. Dept of HHS to expand access to rapid point-of-care testing for COVID-19
On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…
-
BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…
-
Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
-
AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics
Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
On Jul. 15, 2020, a Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19. Published…
-
Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19 nasal spray…
-
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
On Jul. 14, 2020, a study by National Institutes of Health (NIH) researchers reported the placental membranes that…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH researchers generated complete human X chromosome sequence
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes…
-
Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
-
Experimental COVID-19 vaccine safe, generated immune response
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
-
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
-
HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
-
Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…
-
Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia
On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…
-
Dynavax announced first participants dosed in phase 1 clinical evaluating Medicago’s COVID-19 vaccine candidate
On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…
-
Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On Jul. 14, 2020, newly designed powered air-purifying respirators (PAPRs), developed by Ford in close collaboration with 3M,…
-
Celdara Medical announced the Pandemic Security Initiative
On Jul. 14, 2020, Celdara Medical announced the launch of its Pandemic Security Initiative, harnessing the resources needed…
-
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
-
Engineered llama antibodies neutralised Covid-19 virus
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
-
Junshi Biosciences and Lonza announced partnership to produce a neutralizing antibody tackling COVID-19
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
-
Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
-
Deadly rabbit virus spread in the US
On Jul. 13, 2020, an emerging virus threatens both wild and pet rabbits in the U.S. The fatal…
-
Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVID
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
-
Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesﾒ four investigational vaccine candidates from…
-
OPKO Health’s BioReference Laboratories to provide COVID-19 testing for National Basketball Association players and employees
On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight…
-
Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19
On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…
